Diverse roles of hepatitis B virus in liver cancer

Current Opinion in Virology

Volumn 2, Issue 4, 2012, Pages 467-473

  Fallot, Guillaume ^a   Neuveut, Christine ^b   Buendia, Marie Annick ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS PROTEIN;

AGE; ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CANCER RISK; CAUSE OF DEATH; CHROMOSOMAL INSTABILITY; CHROMOSOME; DIABETES MELLITUS; DIETARY INTAKE; DNA POLYMORPHISM; ENDEMIC DISEASE; EPIGENETICS; GENDER; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIFE CYCLE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MUTAGENESIS; NUTRITION; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; VIREMIA; VIRUS CELL INTERACTION; VIRUS TRANSCRIPTION;

EID: 84865116888     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.05.008     Document Type: Review

References (53)

1. D. Ganem, and A.M. Prince Hepatitis B virus infection - natural history and clinical consequences New England Journal of Medicine 350 2004 1118 1129 (Pubitemid 38298992)
2. J.S. Pagano, M. Blaser, M.A. Buendia, B. Damania, K. Khalili, N. Raab-Traub, and B. Roizman Infectious agents and cancer: criteria for a causal relation Seminars in Cancer Biology 14 2004 453 471 (Pubitemid 39360994)
3. D.M. Parkin The global health burden of infection-associated cancers in the year 2002 International Journal of Cancer 118 2006 3030 3044
4. H.I. Yang, M.F. Yuen, H.L. Chan, K.H. Han, P.J. Chen, D.Y. Kim, S.H. Ahn, C.J. Chen, V.W. Wong, and W.K. Seto Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score Lancet Oncology 12 2011 568 574
5. C. Brechot Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms Gastroenterology 127 2004 S56 S61
6. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917 (Pubitemid 37518510)
7. F.V. Chisari, M. Isogawa, and S.F. Wieland Pathogenesis of hepatitis B virus infection Pathologie Biologie 58 2010 258 266
8. T.W. Kang, T. Yevsa, N. Woller, L. Hoenicke, T. Wuestefeld, D. Dauch, A. Hohmeyer, M. Gereke, R. Rudalska, and A. Potapova Senescence surveillance of pre-malignant hepatocytes limits liver cancer development Nature 479 2011 547 551 This study illustrates how the cellular senescence program is involved in preventing tumor development by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.
9. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669 (Pubitemid 351615417)
10. J.M. Lee, C.M. Wong, and I.O. Ng Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations Cancer Research 68 2008 5988 5996
11. Y. Kanai Genome-wide DNA methylation profiles in precancerous conditions and cancers Cancer Science 101 2010 36 45
12. T.H. Um, H. Kim, B.K. Oh, M.S. Kim, K.S. Kim, G. Jung, and Y.N. Park Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis Journal of Hepatology 54 2011 939 947
13. S. Imbeaud, Y. Ladeiro, and J. Zucman-Rossi Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma Seminars in Liver Disease 30 2010 75 86
14. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 International Journal of Cancer 127 2010 2893 2917
15. W. Szmuness Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association Progress in Medical Virology 24 1978 40 69
16. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, and A. Forner Sorafenib in advanced hepatocellular carcinoma New England Journal of Medicine 359 2008 378 390
17. S. Seitz, S. Urban, C. Antoni, and B. Bottcher Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions EMBO Journal 26 2007 4160 4167 (Pubitemid 47462100)
18. C. Neuveut, Y. Wei, and M.A. Buendia Mechanisms of HBV-related hepatocarcinogenesis Journal of Hepatology 52 2010 594 604
19. J. Lucifora, S. Arzberger, D. Durantel, L. Belloni, M. Strubin, M. Levrero, F. Zoulim, O. Hantz, and U. Protzer Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection Journal of Hepatology 55 2011 996 1003
20. K. Visvanathan, N.A. Skinner, A.J. Thompson, S.M. Riordan, V. Sozzi, R. Edwards, S. Rodgers, J. Kurtovic, J. Chang, and S. Lewin Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Hepatology 45 2007 102 110 (Pubitemid 46150869)
21. Y. Wei, C. Neuveut, P. Tiollais, and M.A. Buendia Molecular biology of the hepatitis B virus and role of the X gene Pathologie Biologie 58 2010 267 272
22. I. Bar-Yishay, Y. Shaul, and A. Shlomai Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression Liver International 31 2011 282 290
23. S.H. Wang, S.H. Yeh, W.H. Lin, K.H. Yeh, Q. Yuan, N.S. Xia, D.S. Chen, and P.J. Chen Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha Gastroenterology 142 2012 989-998 e984 This study, showing that ERα downregulates the activity of the HBV enhancer I through its binding to HNF4α, provides a possible explanation for gender discrepancies in HBV replication level and risk of HCC occurrence.
24. C.T. Bock, P. Schranz, C.H. Schroder, and H. Zentgraf Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell Virus Genes 8 1994 215 229 (Pubitemid 24239779)
25. •] describe for the first time the chromatin-like organization of HBV cccDNA in the nucleus of infected cells. (Pubitemid 33029975)
26. D. Cougot, Y. Wu, S. Cairo, J. Caramel, C.A. Renard, L. Levy, M.A. Buendia, and C. Neuveut The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription Journal of Biological Chemistry 282 2007 4277 4287 (Pubitemid 47100918)
27. L. Belloni, T. Pollicino, F. De Nicola, F. Guerrieri, G. Raffa, M. Fanciulli, G. Raimondo, and M. Levrero Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function Proceedings of the National Academy of Sciences of the United States of America 106 2009 19975 19979 These two studies have elucidated key mechanisms underlying HBx transcritional activity, in particular the physical presence of HBx on cellular and viral target promoters and its ability to modulate epigenetic regulation of transcription.
28. T. Pollicino, L. Belloni, G. Raffa, N. Pediconi, G. Squadrito, G. Raimondo, and M. Levrero Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones Gastroenterology 130 2006 823 837 In this pioneer study, the authors provide evidence for epigenetic regulation of viral replication at the nuclear HBV minichromosome. (Pubitemid 43374531)
29. D. Cougot, E. Allemand, L. Riviere, S. Benhenda, K. Duroure, F. Levillayer, C. Muchardt, M.A. Buendia, and C. Neuveut Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription Science Signaling 5 2012 ra1 The authors report that HBV recruits CREB in the transcription of its own DNA, and that CREB phosphorylation and activity on HBV DNA is prolonged by HBx-mediated inhibition of PP1 activity. It illustrates one of the mechanisms used by the virus for manipulating signaling pathways in the host cell to ensure its own replication and survival.
30. L. Belloni, L. Allweiss, F. Guerrieri, N. Pediconi, T. Volz, T. Pollicino, J. Petersen, G. Raimondo, M. Dandri, and M. Levrero IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome Journal of Clinical Investigation 122 2012 529 537 This study shows that IFN-α repression of HBV transcription is mediated by recruitment of several corepressors and components of the polycomb repressive complex 2 (PRC2) at the HBV enhancer I, thereby modifying histone tail acetylation and methylation.
31. A. Das, and M.K. Maini Innate and adaptive immune responses in hepatitis B virus infection Digestive Diseases 28 2010 126 132
32. Bertoletti A, Ferrari C: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2011, Dec 9. [Epub ahead of print].
33. I. Chemin, and F. Zoulim Hepatitis B virus induced hepatocellular carcinoma Cancer Letters 286 2009 52 59
34. R. Bataller, and D.A. Brenner Liver fibrosis Journal of Clinical Investigation 115 2005 209 218 (Pubitemid 40385459)
35. M. Hatziapostolou, C. Polytarchou, E. Aggelidou, A. Drakaki, G.A. Poultsides, S.A. Jaeger, H. Ogata, M. Karin, K. Struhl, and M. Hadzopoulou-Cladaras An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis Cell 147 2011 1233 1247
36. A. Marchio, P. Pineau, M. Meddeb, B. Terris, P. Tiollais, A. Bernheim, and A. Dejean Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients Oncogene 19 2000 3733 3738 (Pubitemid 30621178)
37. P. Laurent-Puig, P. Legoix, O. Bluteau, J. Belghiti, D. Franco, F. Binot, G. Monges, G. Thomas, P. Bioulac-Sage, and J. Zucman-Rossi Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 120 2001 1763 1773 (Pubitemid 32523494)
38. X. Chen, S.T. Cheung, S. So, S.T. Fan, C. Barry, J. Higgins, K.M. Lai, J. Ji, S. Dudoit, and I.O. Ng Gene expression patterns in human liver cancers Molecular Biology of the Cell 13 2002 1929 1939 (Pubitemid 34651483)
39. S. Boyault, D.S. Rickman, A. de Reynies, C. Balabaud, S. Rebouissou, E. Jeannot, A. Herault, J. Saric, J. Belghiti, and D. Franco Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52 In this study, gene expression profiles have identified distinctive features of HBV-related tumors. (Pubitemid 46144363)
40. C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier, I.B. Maad, J. Calderaro, P. Bioulac-Sage, M. Letexier, and F. Degos Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
41. ••] report exomic sequencing studies of primary liver tumors, demonstrating high genetic heterogeneity and the influence of etiology on the mutational spectrum.
42. Y. Murakami, K. Saigo, H. Takashima, M. Minami, T. Okanoue, C. Brechot, and P. Paterlini-Brechot Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut 54 2005 1162 1168 Comprehensive analysis of HBV insertion sites in a large series of HCCs demonstrates that HBV DNA integrates preferentially into actively transcribed regions, close to or within cellular genes. (Pubitemid 41025914)
43. A. Dejean, L. Bougueleret, K.H. Grzeschik, and P. Tiollais Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma Nature 322 1986 70 72 (Pubitemid 16061510)
44. J. Wang, X. Chenivesse, B. Henglein, and C. Bréchot Hepatitis B virus integration in a cyclin A gene in a human hepatocellular carcinoma Nature 343 1990 555 557
45. S. Benhenda, D. Cougot, M.A. Buendia, and C. Neuveut Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis Advances in Cancer Research 103 2009 75 109
46. L. Studach, W.H. Wang, G. Weber, J. Tang, R.L. Hullinger, R. Malbrue, X. Liu, and O. Andrisani Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy Journal of Biological Chemistry 285 2010 30282 30293 This study identifies the activation of Plk1 by HBx at the G2 phase as a key step in the propagation of DNA damage and generation of polyploidy in immortalized hepatocytes. This mechanism was firmed-up in the liver of different animal models by further studies of the same group.
47. S. Martin-Lluesma, C. Schaeffer, E.I. Robert, P.C. van Breugel, O. Leupin, O. Hantz, and M. Strubin Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1 Hepatology 48 2008 1467 1476 The authors highlight the effects of HBx binding to DDB1 on chromosomal instability. Thus, besides its essential role in promoting HBV replication, this interaction might contribute to HCC development.
48. T. Li, E.I. Robert, P.C. van Breugel, M. Strubin, and N. Zheng A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery Nature Structural & Molecular Biology 17 2010 105 111
49. Y. Wen, V.S. Golubkov, A.Y. Strongin, W. Jiang, and J.C. Reed Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation Journal of Biological Chemistry 283 2008 2793 2803
50. L. Rakotomalala, L. Studach, W.H. Wang, G. Gregori, R.L. Hullinger, and O. Andrisani Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy Journal of Biological Chemistry 283 2008 28729 28740
51. L.L. Studach, L. Rakotomalala, W.H. Wang, R.L. Hullinger, S. Cairo, M.A. Buendia, and O.M. Andrisani Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression Hepatology 50 2009 414 423
52. W.H. Wang, L.L. Studach, and O.M. Andrisani Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication Hepatology 53 2011 1137 1147
53. S. Kim, S.Y. Park, H. Yong, J.K. Famulski, S. Chae, J.H. Lee, C.M. Kang, H. Saya, G.K. Chan, and H. Cho HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint Oncogene 27 2008 3457 3464 (Pubitemid 351769311)